Brendan P. Eckelman, Chief Scientific Officer, 10% Owner at Inhibrx, Inc. (INBX), sold 40,000 shares at $17.70 ($720K) on 2022-08-02, disclosed to the SEC on 2022-08-04.
Open-market sale of $720k INBX by Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.70 | 24,500 | $434K | 60.2% |
| 2 | $18.47 | 15,500 | $286K | 39.8% |
| Total | $18.00 avg | 40,000 | $720K | 100% |
| Filing → |
| INBX | SELL | 2022-12-07 | $2.1M | — | Filing → |
| INBX | SELL | 2022-11-02 | $2.7M | — | Filing → |
| INBX | SELL | 2022-10-05 | $2.2M | — | Filing → |